Prosecution Insights
Prosecution Insights
Tech Center 3600 • Art Units: 1631 1684 3619
This examiner grants 25% of resolved cases
Pablo S. Whaley is a patent examiner assigned to Art Unit 1631 within Tech Center 3600. The examiner's professional record includes 538 resolved cases. The data indicates an allowance rate of 25.1% for these applications. This figure serves as a primary indicator of the probability of success for cases on this docket. Additionally, the median days to allowance is 1907, which establishes a specific timeframe for the prosecution process. These metrics offer a foundational understanding of the examiner's approach to patent applications.
The interview lift for this examiner is 21.4%. This 21.4% lift shows the change in the likelihood of allowance when an interview is conducted compared to the 25.1% base rate. With 538 resolved cases, the data provides a view of the examiner's historical performance. The 1907-day median pendency is a key metric for managing client expectations regarding the duration of the patent application process in Tech Center 3600. Practitioners should evaluate the allowance rate and the interview lift to determine the most effective strategy for their specific cases.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18130134 | METHODS, SYSTEMS, AND COMPUTER READABLE MEDIA FOR EVALUATING VARIANT LIKELIHOOD | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 17136800 | SYSTEMS AND METHODS FOR MAPPING SEQUENCE READS | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 17616494 | Likelihood Ratios for Out-of-Distribution Detection | Final Rejection | Google LLC |
| 17786617 | Transdermal Sedative Release Control in Autonomous Imaging | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 19390421 | COMPUTING ARCHITECTURE FOR COMPONENT-LEVEL PROGRESSION ASSESSMENT IN COMPOSITE ENTITIES | Final Rejection | Generation Lab, Inc. |
| 17764074 | RANKING NEOANTIGENS FOR PERSONALIZED CANCER VACCINE | Final Rejection | Amazon Technologies, Inc. |
| 17753871 | Methods of Treatments Based Upon Molecular Characterization of Breast Cancer | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17661674 | ADAPTIVE SIGNAL PROCESSING | Non-Final OA | Medtronic MiniMed, Inc. |
| 17642524 | ANALYSIS METHODS FOR MULTIPLEX TISSUE IMAGING INCLUDING IMAGING MASS CYTOMETRY DATA | Non-Final OA | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 17696102 | MACHINE LEARNING TO CORRECT FOR NONPHOTOCHEMICAL QUENCHING IN HIGH-FREQUENCY, IN VIVO FLUOROMETER DATA | Final Rejection | Rensselaer Polytechnic Institute |
| 17791970 | ATAC-SEQ DATA NORMALIZATION AND METHOD FOR UTILIZING SAME | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 17388393 | System and Method for Determining Caloric Requirements of an Animal | Final Rejection | Hill's Pet Nutrition, Inc. |
| 17383750 | System and Method for Determining Caloric Requirements of an Animal Based on a Plurality of Durational Parameters | Final Rejection | Hill's Pet Nutrition, Inc. |
| 17334109 | METHODS OF STRATIFYING AND TREATING A SUB-POPULATION OF INFLAMMATORY BOWEL DISEASE PATIENTS | Final Rejection | Cedars-Sinai Medical Center |
| 19183496 | METHODS AND SYSTEMS FOR PROCESSING GENETIC VARIATIONS AND PHENOTYPES | Final Rejection | GeneDx, LLC |
| 19088442 | METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY | Non-Final OA | Myriad Genetics, Inc. |
| 17930505 | DEEP NEURAL NETWORKS FOR ESTIMATING POLYGENIC RISK SCORES | Non-Final OA | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA |
| 17728224 | METHOD AND KIT FOR EVALUATING PROGNOSIS IN PATIENT WITH BREAST CANCER | Non-Final OA | CHANG GUNG MEMORIAL HOSPITAL, LINKOU |
| 17660339 | Decision Support Tool for Endovascular Procedures | Non-Final OA | Mentice AB |
| 18329451 | SYSTEM AND METHOD FOR OPTIMIZING INSULIN DOSAGES FOR DIABETIC SUBJECTS | Non-Final OA | Glytec, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy